Literature DB >> 7679313

New options for patients with benign prostatic hyperplasia.

B Ellenberger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679313      PMCID: PMC1490527     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Surgical treatment for benign prostatic hyperplasia.

Authors:  C Brendler; P Schlegel; J Dowd; R Kirby; F Zattoni
Journal:  Cancer       Date:  1992-07-01       Impact factor: 6.860

2.  Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia.

Authors:  N P Roos; J E Wennberg; D J Malenka; E S Fisher; K McPherson; T F Andersen; M M Cohen; E Ramsey
Journal:  N Engl J Med       Date:  1989-04-27       Impact factor: 91.245

3.  Differential effect of 5 alpha-reductase inhibition and castration on androgen-regulated gene expression in rat prostate.

Authors:  R S Rittmaster; K E Magor; A P Manning; R W Norman; C B Lazier
Journal:  Mol Endocrinol       Date:  1991-07

4.  The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.

Authors:  G J Gormley; E Stoner; R C Bruskewitz; J Imperato-McGinley; P C Walsh; J D McConnell; G L Andriole; J Geller; B R Bracken; J S Tenover
Journal:  N Engl J Med       Date:  1992-10-22       Impact factor: 91.245

5.  Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects.

Authors:  D P Lookingbill; L M Demers; C Wang; A Leung; R S Rittmaster; R J Santen
Journal:  J Clin Endocrinol Metab       Date:  1991-06       Impact factor: 5.958

6.  The development of human benign prostatic hyperplasia with age.

Authors:  S J Berry; D S Coffey; P C Walsh; L L Ewing
Journal:  J Urol       Date:  1984-09       Impact factor: 7.450

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.